Although our data indicated that PTBP1‐mediated AS of DNMT3B enhanced radioresistance in PCa, further evaluation of PTBP1 expression in radioresistant patients is needed to confirm its clinical relevance. The gene discussed is PTBP1; the disease is posterior cortical atrophy.